PIK3R4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63247193540883E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.6144996450862E-10 |
Normal-vs-Stage2 |
2.78989997770651E-09 |
Normal-vs-Stage3 |
8.88178419700125E-16 |
Normal-vs-Stage4 |
1.77491354946824E-12 |
Stage1-vs-Stage2 |
1.554200E-01 |
Stage1-vs-Stage3 |
3.824300E-04 |
Stage1-vs-Stage4 |
1.661980E-03 |
Stage2-vs-Stage3 |
2.474000E-01 |
Stage2-vs-Stage4 |
2.637000E-01 |
Stage3-vs-Stage4 |
9.303800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63880020664919E-12 |
Normal-vs-AfricanAmerican |
1.55699997339553E-09 |
Normal-vs-Asian |
1.701320E-03 |
Caucasian-vs-AfricanAmerican |
6.716600E-01 |
Caucasian-vs-Asian |
8.720400E-01 |
AfricanAmerican-vs-Asian |
9.948600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
9.57220003261483E-09 |
Male-vs-Female |
4.46790000000474E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.99480000032615E-07 |
Normal-vs-Age(41-60Yrs) |
1.09340314580209E-11 |
Normal-vs-Age(61-80Yrs) |
1.62847513252018E-12 |
Normal-vs-Age(81-100Yrs) |
6.26609986120741E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.432400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.187800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.403600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.084440E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.267600E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.750400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.111200E-01 |
Normal-vs-Grade 2 |
1.21480003834051E-09 |
Normal-vs-Grade 3 |
1.62592161956354E-12 |
Normal-vs-Grade 4 |
1.62558855265615E-12 |
Grade 1-vs-Grade 2 |
2.177900E-02 |
Grade 1-vs-Grade 3 |
8.220700E-04 |
Grade 1-vs-Grade 4 |
1.155660E-04 |
Grade 2-vs-Grade 3 |
6.516200E-03 |
Grade 2-vs-Grade 4 |
7.70060000000461E-05 |
Grade 3-vs-Grade 4 |
3.410500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.36889999960921E-07 |
Normal-vs-ccB subtype |
1.62492241884138E-12 |
ccA subtype-vs-ccB subtype |
3.15880000001378E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.66289204628356E-12 |
Normal-vs-N1 |
3.57570000000251E-05 |
N0-vs-N1 |
4.747000E-01 |
|
|